Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Retinoic Acid for COVID-19 Anosmia
NCT05002530Phase 4Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Nov 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, open-label trial of isotretinoin and tretinoin in anosmia (3 arms), sponsored by Kafrelsheikh University. Primary endpoint: Improvement of olfaction at 3 weeks. Status: unknown.
02
Drugs
isotretinointretinoin
03
Conditions
anosmia
Beyond the preview
Go deeper on NCT05002530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05002530.